Vimta Labs Limited (VIMTALABS) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Vimta Labs Limited stock ₹452, price ₹494, that is 8.5% below the price, quality 49 out of 100. Rating: fairly valued. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Vimta Labs Limited
VIMTALABS · NSEThe stock is already about fairly priced, weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 14, 2026.
How to read this chart
60‑month range ₹135.85 – ₹873.97 · fair‑value band ₹258.67 – ₹719.58 · the ₹494.25 price screens above the ₹452.37 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 14, 2026.
Every Wednesday you see whether Vimta Labs is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Vimta Labs Limited provides contract research and testing services in India and internationally.
Show moreShow less
The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies.
It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages.
In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components.
It provides solutions to agriculture, biologics and biosimilars, home and personal care, medical device, specialty chemicals, food, electrical and electronics, nutraceuticals, water and beverages, pharmaceuticals, crop care, environment, health and safety, and packaging industries.
Vimta Labs Limited was founded in 1984 and is headquartered in Hyderabad, India.
Stock analysis
Vimta Labs Limited (VIMTALABS) currently trades at ₹494.25, while our model-based Fair Value estimate is ₹452.37, so the stock looks roughly fairly valued today (gap 9.3%).
Show more
Valuation
Bull case: the Multiples group reads highest at a median of ₹386.48 per share, and 1 of the 26 models we run sit above the ₹494.25 price.
Bear case: the Economic Profit group reads lowest at ₹116.64, and 25 of the 26 models stay below the price. Data coverage for this calculation is high.
Scenario range: ₹258.67 (bear) to ₹719.58 (bull), the price of ₹494.25 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Vimta Labs Limited reported revenue of ₹4.1B in FY2026 versus ₹2.8B in FY2022, a compound +10.2%/yr. Reported net income was ₹775M in FY2026, compounding +17.0%/yr from FY2022.
Key figures
Market cap ₹22.3B (≈ $236M) Micro · P/E ratio 28.0 · P/S ratio 5.29 · EPS (TTM) ₹17.66 · Dividend yield 0.4% · Net margin 18.9% · Return on equity 18.6% · Return on assets (EBIT) 17.8% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 77 out of 100 (medium confidence).
What moves the price
The share trades about 25% below its 52-week high and 30% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −10% fair-value upside, at −9%, VIMTALABS screens cheaper than that median.
Fair Value models
All 26 models by family
The fair value above starts from this blend and is adjusted for dilution from new shares.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
Watch VIMTALABS, get fair value alerts →
Compare Vimta Labs Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Diagnostics & Research · 150 stocks
Valuation Multiplesvs Diagnostics & Research median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Price/FCF by industry
- Debt-to-equity by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Diagnostics & Research stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| WuXi AppTec Co 603259 | ¥144.41 | ¥164.66 | +14% | vs VIMTALABS |
| IQVIA Holdings IQV | $265.12 | $291.63 | +10% | vs VIMTALABS |
| Illumina, Inc ILMN | $207.01 | $227.71 | +10% | vs VIMTALABS |
| Thermo Fisher Scientific Inc TMO | $700.22 | $686.04 | −2% | vs VIMTALABS |
| Danaher Corporation DHR | $233.02 | $209.18 | −10% | vs VIMTALABS |
| IDEXX Laboratories, Inc IDXX | $704.23 | $496.48 | −30% | vs VIMTALABS |
| Lonza Group LONN | CHF 670.20 | CHF 259.80 | −61% | vs VIMTALABS |
| Mettler-Toledo International Inc MTD | $1,739 | $655.06 | −62% | vs VIMTALABS |
| Agilent Technologies, Inc A | $173.96 | $64.53 | −63% | vs VIMTALABS |
| Waters Corporation WAT | $460.25 | $91.26 | −80% | vs VIMTALABS |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Vimta Labs Limited (VIMTALABS) overvalued or undervalued?
What is the fair value of VIMTALABS?
What is the quality score of VIMTALABS?
What is the price target for Vimta Labs Limited (VIMTALABS)?
What is the Vimta Labs Limited stock forecast for 2026?
What is the revenue of Vimta Labs Limited (VIMTALABS)?
Does Vimta Labs Limited pay a dividend?
How much is the dividend of Vimta Labs Limited (VIMTALABS) and when is the ex-dividend date?
What growth is priced into Vimta Labs Limited (VIMTALABS)?
What discount rate (WACC) does the fair value of VIMTALABS use?
What is a reverse DCF?
How much growth has Vimta Labs Limited (VIMTALABS) delivered so far?
How fast is the sector of Vimta Labs Limited (VIMTALABS) growing?
What is the free cash flow yield of Vimta Labs Limited (VIMTALABS)?
What is the intrinsic value of Vimta Labs Limited (VIMTALABS)?
Is Vimta Labs Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of VIMTALABS?
How much is Vimta Labs Limited worth?
What do the bullish and bearish scenarios say about VIMTALABS?
What is the P/E ratio of VIMTALABS?
How solid is the balance sheet of Vimta Labs Limited (VIMTALABS)?
How far is VIMTALABS from its 52-week high?
Which stocks are comparable to Vimta Labs Limited?
Is Vimta Labs Limited stock attractive at the current price?
How is the fair value of VIMTALABS calculated?
Is it still worth investing in stocks now?
What is the share price of Vimta Labs Limited (VIMTALABS)?
What should I pay attention to with Vimta Labs Limited right now?
Where does the earnings growth of Vimta Labs Limited (VIMTALABS) come from?
Key figures of Vimta Labs Limited
How large is the market capitalisation of Vimta Labs Limited (VIMTALABS)?
What is the P/S ratio of Vimta Labs Limited (VIMTALABS)?
What are the earnings per share of Vimta Labs Limited (VIMTALABS)?
What is the dividend yield of Vimta Labs Limited (VIMTALABS)?
What is the net margin of Vimta Labs Limited (VIMTALABS)?
What is the return on equity of Vimta Labs Limited (VIMTALABS)?
What is the EBIT return on assets of Vimta Labs Limited (VIMTALABS)?
What is the operating margin of Vimta Labs Limited (VIMTALABS)?
How fast is revenue growing at Vimta Labs Limited (VIMTALABS)?
How fast are earnings growing at Vimta Labs Limited (VIMTALABS)?
How much net cash does Vimta Labs Limited (VIMTALABS) hold?
Watch Vimta Labs Limited in the live analysis
One click puts Vimta Labs Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.